Intellia Therapeutics (NTLA) Shares Issued (2016 - 2026)

Intellia Therapeutics (NTLA) has 11 years of Shares Issued data on file, last reported at $750.0 million in Q1 2026.

• Quarterly Shares Issued changed N/A year-over-year to $750.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $766.3 million (up 338.03% YoY) and the FY2025 annual result came in at $2.6 million, down 98.54% from the prior year.
• Shares Issued grew to $750.0 million in Q1 2026 per NTLA's latest filing, from $1.4 million in the prior quarter.
• Across five years, Shares Issued topped out at $750.0 million in Q1 2026 and bottomed at -$386.7 million in Q2 2022.
• The 5-year median for Shares Issued is $1.4 million (2025), against an average of $90.0 million.
• The widest annual swing landed in 2022, when Shares Issued slumped 773.29%; it then soared 17511.06% in 2024.
• Tracing NTLA's Shares Issued over 5 years: stood at $398.9 million in 2022, then tumbled by 99.75% to $995000.0 in 2023, then soared by 17511.06% to $175.2 million in 2024, then tumbled by 99.23% to $1.4 million in 2025, then surged by 55373.37% to $750.0 million in 2026.
• Per Business Quant, the three latest NTLA Shares Issued figures stand at $750.0 million (Q1 2026), $1.4 million (Q4 2025), and $1.2 million (Q3 2025).

Peer Comparison